Scholar Rock Shares Rise 9.1% After FDA Approves ISEMBYLD for Spinal Muscular Atrophy
Corroborated by 3 sources from 3 publishers
ushealth1d ago
TL;DR
Scholar Rock Shares Rise 9.1% After FDA Approves ISEMBYLD for Spinal Muscular Atrophy
Sources
1
Yahoo Finance News
https://finance.yahoo.com/healthcare/articles/scholar-rock-shares-rise-9-120835864.html
1d ago
2
Investing.com News
https://www.investing.com/news/analyst-ratings/scholar-rock-shares-td-cowen-keeps-buy-on-fda-approval-broad-label-93CH-4900137
1d ago
3
Seeking Alpha Market News
https://seekingalpha.com/article/4946041-scholar-rock-holding-corporation-srrk-discusses-fda-approval-and-clinical-impact-of-isembyld?source=feed_all_articles
1d ago